Johns Hopkins Tests Deliberate Pacing Trick to Rescue Failing Hearts
A pilot trial explores whether intentionally inducing brief daily dyssynchrony via pacemaker can retrain failing heart muscle in humans.
20 articles
A pilot trial explores whether intentionally inducing brief daily dyssynchrony via pacemaker can retrain failing heart muscle in humans.
A Phase IIa trial explores whether the HIF-PHI drug daprodustat can safely replace EPO injections in hemodialysis patients with anemia.
A completed Phase 3 trial tests placental MSC secretome injections against placebo in 60 GvHD patients at an Iranian hospital.
New trial tests whether PRP injections can reduce tennis elbow pain better than standard treatments in 72 participants.
A Phase 2 trial investigates whether thiethylperazine, a decades-old antiemetic, can flush toxic amyloid beta from the brains of early AD patients.
Small trial tests blood-derived therapy for persistent post-surgical ear infections that resist standard treatments.
A Phase 4 trial compares two antiretroviral strategies in treatment-naive HIV patients with dangerously low CD4 counts below 100.
MD Anderson's Phase 1/2 trial explored injecting rituximab directly into spinal fluid to target CNS lymphoid malignancies.
Autologous stem cell injections tested in patients with severe leg circulation problems who had no surgical options.
Contraloid acetate, an oral all-D-peptide designed to disassemble toxic amyloid-beta oligomers, completed its first-in-human safety trial in 40 healthy volunteers.
A Phase 4 trial tests whether simplifying HIV treatment to two drugs worsens hidden viral replication and immune dysfunction.
Military study tests regenerative PRP injections against placebo for facet joint pain in 91 participants.
A completed RCT tests whether 1-hour pathogen detection paired with antimicrobial stewardship slashes broad-spectrum antibiotic days in HAP patients.
150-person trial tests whether PRP injections can reduce knee pain and improve function better than placebo in osteoarthritis patients.
Clinical trial tests platelet-rich plasma therapy for shoulder osteoarthritis in 91 patients over 5 months.
Small pilot study explores whether PRP injections can safely reverse aging signs in women's facial and hand skin.
A Phase 1/2 trial tests whether dexmedetomidine can enhance the brain's glymphatic system to clear amyloid and tau during sleep.
A first-in-human multiple-ascending-dose trial tests Contraloid, an oral peptide designed to disassemble toxic amyloid-beta oligomers linked to Alzheimer's disease.
Clinical trial investigated whether pressurized oxygen treatments could stimulate new blood vessel growth in elderly participants.
Italian researchers developed a biosensor to track extracellular vesicles in blood, potentially personalizing stroke rehabilitation.